Biotech · Private company
Symphogen A/S
Track this companyFree. Adds Symphogen A/S to your Dealase workspace and tells you when its record changes.
Clinical trials110 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- Best Supportive Care (BSC)Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabinePhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Fluorouracil (5-FU)Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- FOLFIRIPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- FutuximabPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- ModotuximabPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sym001Phase 2 · Immune Thrombocytopenic PurpuraClinicalTrials.gov · fetched Nov 12, 2026
- Sym004Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sym004 (12 mg/kg)Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sym004 (9/6 mg/kg)Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sym013Phase 2 · OncologyClinicalTrials.gov · fetched Nov 12, 2026
- Sym015Phase 2 · OncologyClinicalTrials.gov · fetched Nov 12, 2026
- Irinotecan HydrochloridePhase 1 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sym021Phase 1 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sym022Phase 1 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sym023Phase 1 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sym024Phase 1 · Metastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesPHASE1 · COMPLETED · started Nov 19, 2020ClinicalTrials.gov NCT04672434 · fetched Nov 12, 2026
- Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesPHASE1 · COMPLETED · started Oct 12, 2020ClinicalTrials.gov NCT04641871 · fetched Nov 12, 2026
- Sym004 Versus Futuximab or Modotuximab in Patients With mCRCPHASE2 · TERMINATED · started Nov 29, 2018ClinicalTrials.gov NCT03549338 · fetched Nov 12, 2026
- Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or LymphomasPHASE1 · COMPLETED · started May 24, 2018ClinicalTrials.gov NCT03489343 · fetched Nov 12, 2026
- Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or LymphomasPHASE1 · COMPLETED · started May 8, 2018ClinicalTrials.gov NCT03489369 · fetched Nov 12, 2026
- Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or LymphomasPHASE1 · COMPLETED · started Nov 20, 2017ClinicalTrials.gov NCT03311412 · fetched Nov 12, 2026
- Sym013 (Pan-HER) in Patients With Advanced Epithelial MalignanciesPHASE1_PHASE2 · TERMINATED · started Nov 1, 2016ClinicalTrials.gov NCT02906670 · fetched Nov 12, 2026
- Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer PatientsPHASE1_PHASE2 · TERMINATED · started Mar 15, 2016ClinicalTrials.gov NCT02568046 · fetched Nov 12, 2026
- Sym015 (Anti-MET) in Patients With Advanced Solid Tumor MalignanciesPHASE1_PHASE2 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02648724 · fetched Nov 12, 2026
- Sym004 vs Standard of Care in Subjects With Metastatic Colorectal CancerPHASE2 · COMPLETED · started Mar 6, 2014ClinicalTrials.gov NCT02083653 · fetched Nov 12, 2026
- Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)PHASE2 · COMPLETED · started Jul 1, 2008ClinicalTrials.gov NCT00718692 · fetched Nov 12, 2026